GlassScriptPhysician profile
Joshua Michael Auer
NPI 1962038356
$5,776.37
in general payments reported to CMS, 2019-2025
31 companies · $1,791 in 2025
The $1,791 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,046 · 2022: $886 · 2023: $966 · 2024: $1,086 · 2025: $1,791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,754 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,753.72 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $801.04 | 2021-2025 | Xtandi, Myrbetriq, Veozah |
| Janssen Biotech, INC. | $758.49 | 2022-2025 | Erleada, Carvykti, Rybrevant |
| Antares Pharma, INC. | $519.28 | 2021 | |
| Dendreon Pharmaceuticals LLC | $515.32 | 2023-2025 | Provenge |
| Sumitomo Pharma America, INC. | $477.92 | 2023-2025 | Gemtesa |
| Abbvie INC. | $396.62 | 2021-2025 | |
| Olympus America INC. | $370.61 | 2022-2025 | Itind System, Soltive |
| Pfizer INC. | $245.43 | 2023-2025 | |
| Kowa Pharmaceuticals America, INC. | $233.68 | 2022-2023 | Seglentis |
| Bayer Healthcare Pharmaceuticals INC. | $208.79 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $208.53 | 2024-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $162.60 | 2023-2025 | Pylarify |
| Tolmar, INC. | $133.65 | 2023-2025 | Jatenzo |
| Medtronic, INC. | $114.67 | 2023 | Interstim |
| Vertex Pharmaceuticals Incorporated | $76.69 | 2024-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $53.71 | 2025 | Purewick Female External Catheter, Bard Urinary Drainage Bag |
| Clarus Therapeutics INC. | $51.33 | 2021 | |
| Urovant Sciences INC | $47.13 | 2021-2022 | |
| Teleflex LLC | $46.46 | 2021 | |
| Myriad Genetic Laboratories, INC. | $45.15 | 2024 | Prolaris |
| Urogen Pharma, INC. | $42.27 | 2023-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $38.11 | 2023 | Aveed, Xiaflex, Edex |
| Avyxa Pharma, LLC | $37.60 | 2025 | |
| Sun Pharmaceutical Industries INC. | $36.68 | 2023 | Yonsa |
| Blue Earth Diagnostics | $31.73 | 2021-2022 | |
| Coloplast Corp | $23.51 | 2025 | |
| 180 Medical, INC. | $23.07 | 2025 | Gentlecath Glide |
| Procept Biorobotics Corporation | $22.62 | 2023 | Aquabeam Robotic System |
| Axonics, INC. | $19.25 | 2023 | Axonics, Bulkamid |
| Lantheus Medical Imaging, INC. | $17.53 | 2024 | |
| Abc Home Medical Supply, INC. | $16.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Auer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.